Hospital Sales end is still near

Discussion in 'Pfizer' started by Anonymous, Sep 3, 2013 at 9:33 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Don't be fooled! Take advantage of the "HOME STUDY" to look for a new job. This is a nice gift of 3 months but Christmas time still will be the end. Don't be so naive!!
     

  2. Anonymous

    Anonymous Guest

    Don't be so negative. You never know what Pfizer is going to do. If you want to jump ship, go ahead. I'm staying.

     
  3. Anonymous

    Anonymous Guest

    Antibiotic’s Label Should Include a Stronger Warning About Higher Mortality Rate, Public Citizen Tells FDA

    Public Citizen Calls on FDA to Require Black Box Warning on Label for the Antibiotic Tigecycline

    WASHINGTON, D.C. – The Food and Drug Administration (FDA) should place a black box warning on an antibiotic used to treat a wide range of infections because of a higher mortality rate associated with taking the drug than other widely used antibiotics, Public Citizen said in a petition sent today to the agency.

    The antibiotic, tigecycline, also known as Tygacil, was approved by the FDA in 2005 to treat complicated skin infections and intra-abdominal infections and in 2009 to treat community-acquired pneumonia.

    But in 2010, the FDA issued a safety alert to health care professionals informing them of an increased mortality rate associated with the use of intravenous tigecycline compared to that of other antibiotics. The agency said that alternatives to tigecycline should be considered in patients with serious infections. At the same time, the FDA required that the drug label be modified to include data about the increased mortality risk, but these warnings were inadequate, Public Citizen said in the petition. Critical safety information does not appear in a black box warning at the top of the label and fails to describe appropriate restrictions on the use of the drug.

    “Given the approximately 30 percent higher rate of mortality in subjects receiving tigecycline, as well the significantly higher rates of failures to cure serious infections, in comparison to subjects treated with comparator antibiotics, the content and placement of the warnings in the current drug label are woefully insufficient,” said Dr. Michael Carome, deputy director of Public Citizen’s Health Research Group. “Because of the increased death rate and the likely inappropriate use of tigecycline as a first-line, rather than last-resort, antibiotic for serious infections without simultaneous administration of other antibiotics, it is inexcusable that there is currently no black box warning for tigecycline. Such a warning, accompanied by stronger warnings describing appropriate restrictions on its use in other parts of the label, clearly is warranted to more effectively advise physicians about the dangers of using tigecycline to treat serious infections and to better protect public health.”

    Public Citizen calls on the FDA to add a black box warning to the antibiotic’s label indicating the increased risk of death and advising that it should be used only as a last-resort antibiotic and then only in combination with one or more bactericidal antibiotics (antibiotics that directly kill bacteria, rather than interfere with bacteria growth). Public Citizen also is petitioning the agency to require an FDA-approved medication guide to be distributed to patients, as well as a “Dear Doctor” letter to physicians, warning them of the dangers of the drug and the need for restricted use.
     
  4. Anonymous

    Anonymous Guest

    How is the OP being negative again? I am sorry, I call that SMART!
     
  5. Anonymous

    Anonymous Guest

    The Doomsday Clock for the sales organization is at 5 minutes to midnight. I saw it in NYC HQ with my own eyes! The end is very near.
     
  6. Anonymous

    Anonymous Guest

    Where is the Pfieldnet link to sign up for voluntary severance and how soon can it begin?
     
  7. Anonymous

    Anonymous Guest

    Well, IS needs to cut $110 million in expenses. Where should we cut? Buehler, anyone? Buehler?
     
  8. Anonymous

    Anonymous Guest

    Where the black UN helicopters circling nearby?
     
  9. Anonymous

    Anonymous Guest

    Sid Wolfe got everything he asked for. Pfizer is screwed!
     
  10. Anonymous

    Anonymous Guest

    This will be the final death knell for this product!! My guess is we will never promote the product again. I, for one, won't miss the product. BYE!!
     
  11. Anonymous

    Anonymous Guest

    And there goes the entire division as well D-day 3rd QTR 2014. Enjoy the many realm of possibilities of BS that has/will come from the mouths of the mgmt. team being in the EPBU. They think all you people are stupid and will believe them.
     
  12. Anonymous

    Anonymous Guest

    It's called pre-call planning. Knowing your customer.
     
  13. Anonymous

    Anonymous Guest

    Naive?

    No, don't be STUPID.

    If you think these "jobs" are going to be around...you are just that!

    Leave this TITANIC before it is too late!
     
  14. Anonymous

    Anonymous Guest

    Here in lies the truth. For those of you who know who Sid Wolfe is, you will know what this means. Thx for the straight talk, transparency. Now we can OWN IT, just like they want.
     
  15. Anonymous

    Anonymous Guest

    Face it, ELT knew for months this was happening. The FDA did not pull this label wording out of a hat. Pfizer drafts it's own label for FDA to approve/add changes.
     
  16. Anonymous

    Anonymous Guest

    So what!?
     
  17. Anonymous

    Anonymous Guest

    Transparency. Straight Talk. OWN IT. Bullshit.
     
  18. Anonymous

    Anonymous Guest

    Leave to go WHERE? Who is hiring IS reps with 15 years of experience?
     
  19. Anonymous

    Anonymous Guest

    I don't think you can be happy under any circumstances.
     
  20. Anonymous

    Anonymous Guest

    Huh? I can't be happy being a whore and getting bytch slapped by a Pfimp